Effects of Omega-3 Fatty Acids on Cancer Risk

Southern California Evidence-Based Practice Center, RAND Health, Santa Monica 90407-2138, USA.
JAMA The Journal of the American Medical Association (Impact Factor: 35.29). 02/2006; 295(4):403-15. DOI: 10.1001/jama.295.4.403
Source: PubMed


Omega-3 fatty acids are purported to reduce the risk of cancer. Studies have reported mixed results.
To synthesize published and unpublished evidence to determine estimates of the effect of omega-3 fatty acids on cancer risk in prospective cohort studies.
Articles published from 1966 to October 2005 identified through MEDLINE, PREMEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and CAB Health; unpublished literature sought through letters to experts in the neutraceutical industry.
A total of 38 articles with a description of effects of consumption of omega-3 fatty acids on tumor incidence, prospective cohort study design, human study population; and description of effect of omega-3 among groups with different levels of exposure in the cohort were included. Two reviewers independently reviewed articles using structured abstraction forms; disagreements were resolved by consensus.
Two reviewers independently abstracted detailed data about the incidence of cancer, the type of cancer, the number and characteristics of the patients, details on the exposure to omega-3 fatty acids, and the elapsed time between the intervention and outcome measurements. Data about the methodological quality of the study were also abstracted.
Across 20 cohorts from 7 countries for 11 different types of cancer and using up to 6 different ways to categorize omega-3 fatty acid consumption, 65 estimates of the association between omega-3 fatty acid consumption were reported. Among these, only 8 were statistically significant. The high degree of heterogeneity across these studies precluded pooling of data. For breast cancer 1 significant estimate was for increased risk (incidence risk ratio [IRR], 1.47; 95% confidence interval [CI], 1.10-1.98) and 3 were for decreased risk (RR, 0.68-0.72); 7 other estimates did not show a significant association. For colorectal cancer, there was 1 estimate of decreased risk (RR, 0.49; 95% CI, 0.27-0.89) and 17 estimates without association. For lung cancer one of the significant associations was for increased cancer risk (IRR, 3.0; 95% CI, 1.2-7.3), the other was for decreased risk (RR, 0.32; 95% CI, 0.13-0.76), and 4 other estimates were not significant. For prostate cancer, there was 1 estimate of decreased risk (RR, 0.43; 95% CI, 0.22-0.83) and 1 of increased risk (RR, 1.98; 95% CI, 1.34-2.93) for advanced prostate cancer; 15 other estimates did not show a significant association. The study that assessed skin cancer found an increased risk (RR, 1.13; 95% CI, 1.01-1.27). No significant associations between omega-3 fatty acid consumption and cancer incidence were found for aerodigestive cancer, bladder cancer, lymphoma, ovarian cancer, pancreatic cancer, or stomach cancer.
A large body of literature spanning numerous cohorts from many countries and with different demographic characteristics does not provide evidence to suggest a significant association between omega-3 fatty acids and cancer incidence. Dietary supplementation with omega-3 fatty acids is unlikely to prevent cancer.

Download full-text


Available from: Marika Suttorp Booth,
  • Source
    • "Concerning cancer, fish oil and -3 fatty acids are believed to have preventive and adjuvant therapeutic properties [48]. However, epidemiological studies of colorectal cancer show conflicting results and meta-analyses on prospective cohort studies showed no or a very weak protective effect of fish or -3 fatty acid consumption [49] [50] [51]. The effect of -3 fatty acids could reflect their indirect and mild anti-inflammatory effect, due to competition of eicosapentaenoic acid (EPA) with arachidonic acid for the enzymatic production of eicosanoids which have anti-inflammatory or pro-inflammatory properties, depending on their precursor [52]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The end products of polyunsaturated fatty acid (PUFA) peroxidation, such as malondialdehyde (MDA), 4-hydroxynonenal (HNE), and isoprostanes (8-iso-PGF2α), are widely used as systemic lipid oxidation/oxidative stress biomarkers. However, some of these compounds have also a dietary origin. Thus, replacing dietary saturated fat by PUFAs would improve health but could also increase the formation of such compounds, especially in the case of a pro-oxidant/antioxidant imbalanced diet. Hence, the possible impact of dietary fatty acids and pro-oxidant compounds was studied in rats given diets allowing comparison of the effects of heme iron vs. ferric citrate and of ω-6- vs. ω-3-rich oil on the level of lipid peroxidation/oxidative stress biomarkers. Rats given a heme iron-rich diet without PUFA were used as controls. The results obtained have shown that MDA and the major urinary metabolite of HNE (the mercapturic acid of dihydroxynonane, DHN-MA) were highly dependent on the dietary factors tested, while 8-iso-PGF2α was modestly but significantly affected. Intestinal inflammation and tissue fatty acid composition were checked in parallel and could only explain the differences we observed to a limited extent. Thus, the differences in biomarkers were attributed to the formation of lipid oxidation compounds in food or during digestion, their intestinal absorption, and their excretion into urine. Moreover, fecal extracts from the rats fed the heme iron or fish oil diets were highly toxic for immortalized mouse colon cells. Such toxicity can eventually lead to promotion of colorectal carcinogenesis, supporting the epidemiological findings between red meat intake and colorectal cancer risk.
    Free Radical Biology and Medicine 03/2015; 83. DOI:10.1016/j.freeradbiomed.2015.02.023 · 5.74 Impact Factor
  • Source
    • "Previous systematic review [36] have evaluated the impact of omega-3 fatty acid supplementation on cancer incidence on the basis of observational studies. These studies encompass a large body of literature spanning numerous cohorts, from many countries, with different demographic characteristics and do not provide any evidence to support a significant association between omega-3 fatty acid and cancer incidence. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Omega-3 fatty acids are known to prevent cardiac death. However, previous observational studies have suggested that omega-3 fatty acids are associated with cancer risk in adults. We conducted a meta-analysis based on randomized controlled trials to evaluate the effect of omega-3 fatty acids on the risk of cancer incidence, nonvascular death, and total mortality. In February 2013, we performed electronic searches in PubMed, EmBase, and the Cochrane Library to identify randomized controlled trials on cancer incidence, nonvascular death, and total mortality. Relative risk (RR) was used to measure the effect of omega-3 fatty acid supplementation on the risk of cancer incidence, nonvascular death, and total mortality using a random-effect model. The analysis was further stratified by factors that could affect the treatment effects. Of the 8,746 identified articles, we included 19 trials reporting data on 68,954 individuals. These studies reported 1,039 events of cancer, 2,439 events of nonvascular death, and 7,025 events of total mortality. Omega-3 fatty acid supplementation had no effect on cancer incidence (RR, 1.10; 95%CI: 0.97-1.24; P = 0.12), nonvascular death (RR, 1.00; 95%CI: 0.93-1.08; P = 1.00), or total mortality (RR, 0.95; 95%CI: 0.88-1.03; P = 0.24) when compared to a placebo. Subgroup analysis indicated that omega-3 fatty acid supplementation was associated with a reduction in total mortality risk if the proportion of men in the study population was more than 80%, or participants received alpha-linolenic acid. Omega-3 fatty acid supplementation does not have an effect on cancer incidence, nonvascular death, or total mortality.
    BMC Public Health 02/2014; 14(1):204. DOI:10.1186/1471-2458-14-204 · 2.26 Impact Factor
  • Source
    • "Long-chain n-3 PUFA have a wide range of well attested health benefits, primarily in brain development in young children and as an important modulator of immune system function, especially the inflammatory response (Simopoulos 1991). As inflammation is central to many chronic disorders of aging and obesity, this subject is important and is regularly reviewed (MacLean et al. 2006; Schmitz and Ecker 2008; Simopoulos 2008; Nicholson et al. 2013). Although a-linolenic acid (C18:3 n-3) is found in leafy green vegetables, some nuts and some oil seed, it appears that only animals or algae can synthesise the long-chain n-3 PUFA docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) (Sprecher 2002). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Humans hunt or raise a wide variety of animals for meat, which vary from free-range to intensively reared. These animals form a valuable part of human nutrition. Their tissues, including the fat, contain vitamin and other essential nutrients necessary for health. However, animal fat from ruminants and other land mammals is usually regarded as saturated. The purpose of this review is partly to examine the basis for the saturated fat hypothesis of cardiovascular disease given more recent research, to examine the human health effects of animal fats, and partly to draw into one place the diverse knowledge about animal fat and the effects of fat on metabolism. Mechanistic understanding of the initiation of the fatty streak and atherosclerosis calls into question the avoidance of ruminant or porcine fat. Due to high levels of oleic acid, a low n-6 : n-3 fatty acid ratio in somegroups, and the presence of specific micronutrients including vitamins and essential fatty acids, animal fats are of benefit in human nutrition. Animal fats can be obtained in minimally processed form making them a convenient source of energy and micronutrients.
    Animal Production Science 01/2014; 54(7):831-855. DOI:10.1071/AN13536 · 1.29 Impact Factor
Show more